Register for email alerts and news feeds:
This journal | BMJ Group
rss
The most recent version of this article was published on 1 July 2006

J Clin Pathol. Published Online First: 28 March 2006. doi:10.1136/jcp.2005.026435
Copyright © 2006 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.

Molecular Pathology

Comparative genomic hybridization (cgh) in malignant Deciduoid mesothelioma

Anna Scattone 1, Antonio Pennella 2, Mattia Gentile 3, Marina Musti 4, Pietro Nazzaro 5, Antonia Lucia Buonadonna 3, Andrea Marzullo 1, Donenica Cavone 4, Lucio Pollice 1 and Gabriella Serio 1*

1 Dpt. of Pathology, Medical School, University of Bari, Italy
2 Dpt. of Surgery and Pathology, Medical School, University of Fo, Italy
3 Medical Genetics, "De Bellis" IRCCS Hospital, Castellana Gro, Italy
4 Dpt. of Internal and Public Medicine, Medical School, University, Italy
5 Dpt. of Clinical Methodology, Medical School, University of Bari., Italy

* To whom correspondence should be addressed. E-mail: g.serio{at}anatopat.uniba.it.

Accepted 23 November 2005


Abstract

Background: Malignant deciduoid mesothelioma (MMD) is a rare variant of epithelioid mesothelioma. Generally, tThis tumour generally has poor prognosis, and it can be asbestos-related. Aim of the study was to identify peculiar genetic alterations responsible for critical phases in MMD pathogenesis and their with prognostic significance.

Methods: Comparative Genomic Hybridization (CGH) was performed oin six cases of malignant pleural deciduoid mesothelioma, four sporadic and two familial. All cases were asbestos-related. Four patients died within during follow-up. Mean survival was 29.5 ± 14.2 months (range 12-43).

Results: In all tumours gGenetic abnormalities were found in all the tumour tissues being most frequently chromosomal gains of 1p, 12q, 17, 8q, 19, and 20. Losses occurred at 13q, 6q, and 9p. Survival was longer in those patients who presented a smaller number of losses in the tumoral chromosomes (≤ 2).

Conclusions: Although deciduoid mesotheliomas present numerous genetic changes, we highlighted demonstrated that certain chromosomal regions are preferentially affected. Our findings show that the number of losses is predictive of the clinical outcome for this subtype of mesothelioma subtype.

Key Words: CGH, Genetic, Mesothelioma, Pleural


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Pathology jobs

Pathology jobs